Lab-equipment management & procurement

01Overview and value chain#

Markers EC: EU Public Procurement Directive 2014/24/EU | OECD: Cross-cutting | Regulator: FDA (USA), EMA (EU), NMPA (China)

A working biology lab runs on two inventories that are rarely in the same system: the instruments it owns, and the reagents and consumables it burns through. Both are usually tracked in spreadsheets, and the reorder goes out by email to whichever supplier a scientist remembers. The platforms in this category collapse that into one workflow — asset and consumable inventory, equipment booking, an order-request approval chain, and a marketplace that quotes across suppliers. Quartzy’s platform serves over 3,000 organisations with access to 10 million lab products; ZAGENO’s marketplace compares price, lead time and availability across more than 6,000 suppliers. The economic argument is mundane and large: duplicate orders, reagents that expire unused, and instruments idle because nobody could see they were free. Labviva reports delivering millions in annual cost savings to top US research universities from the procurement side alone.

The key directions of lab-equipment management and procurement are:

1. Lab asset and consumable inventory (Inventory tracking): a single record of every sample, reagent and instrument with location hierarchies, instant lookup and automatic expiry alerts, replacing the per-freezer spreadsheet. Quartzy extended its location model to multi-layer hierarchies in 2026 so a site, room, freezer, rack and box resolve as one path.
2. Multi-supplier marketplace (Marketplace procurement): an in-app catalogue that aggregates suppliers so a scientist compares products without toggling between vendor sites. ZAGENO aggregates 6,000+ suppliers and millions of products in one marketplace; Quartzy pairs free inventory tooling with an in-app life-science marketplace.
3. Equipment booking and utilisation (Scheduling): calendar-level reservation of shared instruments, which removes schedule clashes and exposes utilisation data that justifies — or avoids — the next capital purchase. This is the core of Calira, released in 2015 and built specifically for life-science research facilities.
4. AI source-to-pay automation (Agentic procurement): the newest layer, applying language models to requisition, quote comparison and approval routing under a compliance trail. Labviva launched “The Agentic Crew” in June 2026, combining specialised small language models with LLM orchestration for end-to-end source-to-pay automation in regulated industries.

Sectoral value chain#

[Requisition] ──> [Catalogue search] ──> [Quote & approval] ──> [Purchase order]
                                                 │
                                      (utilisation data)
                                                 │
                                                 ▼
[Reorder trigger] <─── [Inventory & booking] <───┘

Value chain levels#

Cross-cutting technologies of the sector:

• Barcode and RFID asset tracking (Asset identification): machine-readable labelling that makes a physical scan, not a memory, the source of truth for where a sample or instrument sits.
• ERP and finance integration (Systems integration): connectors that push approved requisitions into the institution’s purchasing system so the lab platform does not become a shadow ledger.
• Spend and utilisation analytics (Analytics): aggregation across sites that shows which suppliers, instruments and consumables actually drive cost, and which assets are underused.

02US#

The US is where this category was built and where the money is: procurement platforms here sell primarily to venture-funded biotech and to research universities under funding pressure.

Quartzy’s inventory-plus-marketplace model, ZAGENO’s 6,000-supplier comparison, Labviva’s agentic source-to-pay#

• Quartzy: founded 2009 and raised $23 million from Avenue Capital Group and BroadOak Capital Partners against a total of $52.02 million, scaling an end-to-end lab operations platform that pairs free inventory tooling with an in-app life-science marketplace across 3,000+ organisations and 10 million products.
• ZAGENO: founded 2015, headquartered in Cambridge, Massachusetts with a Berlin office and roughly 89 staff, running a multi-supplier marketplace that lets biotech and pharma teams compare pricing, lead times and availability across 6,000+ suppliers, from chemicals and antibodies to NGS reagents.
• Labviva: founded 2017 and funded to $53.95 million, targeting regulated-industry procurement specifically — its February 2026 university programme is pitched at institutions navigating rising costs and funding cuts, and its June 2026 “Agentic Crew” release puts small language models behind compliant, defensible source-to-pay automation.

03CN#

China’s version of this market grew out of reagent and consumable distribution rather than software: the leading platforms are one-stop suppliers to universities, research institutes, hospitals and biopharma that added e-commerce and service layers on top of a distribution business.

One-stop life-science supply, authorised-distributor networks, integrated technical services#

• Universal Biotech (优宁维): Shanghai-based, supplying life-science reagents, equipment, consumables and integrated technical services to higher-education institutions, research institutes, hospitals and biopharmaceutical companies, and acting as an authorised East China distributor for lines including BD Pharmingen.
• Distribution-led model: Chinese platforms typically own the supply relationship rather than brokering it, with biochemical product lines fulfilled through partner brands — a structurally different proposition from the US marketplaces, which stay asset-light and neutral between suppliers.
• Institutional buyers: the dominant customer is the state-funded laboratory, and procurement runs through public tender processes, which keeps a large share of Chinese lab purchasing on government bidding platforms rather than on commercial marketplaces.

04EU#

Europe’s contribution is the lab-operations and equipment-scheduling layer, sold to research facilities and core labs rather than to corporate procurement departments.

Equipment booking as the entry point, sample-and-inventory platforms, consolidation into larger suites#

• Calira (formerly Clustermarket): released in 2015 by three Hult International Business School alumni and operating as Clustermarket Ltd t/a Calira, a cloud lab-operations and equipment-booking platform built for life-science research facilities, where the pitch is access to thousands of scientific instruments on demand.
• SciSure (formerly eLabNext): a Netherlands-rooted digital lab platform whose inventory module tracks every sample, reagent and material with instant lookup and automatic expiration alerts, integrated with experiment records, and which extends to instrument integrations such as Eppendorf RackScan.
• Consolidation: the European end of this market is actively consolidating — SciSure acquired Labfolder and Labregister from Labforward, folding electronic lab notebook, inventory and registration tooling into a single scientific-management platform.

05Leading companies and research institutes#

06Tech stack and innovations#

The stack is a thin operational layer over two hard problems: knowing what is physically in the building, and buying more of it without leaving an audit gap.

1. Hierarchical location modelling (Location hierarchy):
   • Assets and samples are addressed by a path — site, room, freezer, rack, box — rather than a free-text note, so a lookup returns a position instead of a hint. Quartzy moved to multi-layer location hierarchies in 2026 as lab teams and storage setups grew.
   • Expiry dates attach to the lot record, and the platform raises alerts before a reagent is wasted rather than after a failed experiment.
2. Multi-supplier catalogue normalisation (Catalogue aggregation):
   • Equivalent products from different vendors are mapped to a comparable unit so price, lead time and availability can be ranked. ZAGENO applies this across 6,000+ suppliers and millions of products.
   • The marketplace is the commercial engine as well as the feature: Quartzy’s platform reaches 10 million lab products across its 3,000+ customer organisations.
3. Compliance-grade procurement automation (Regulated source-to-pay):
   • Labviva’s June 2026 architecture pairs specialised small language models with LLM orchestration, targeting a defensible decision trail — the constraint that separates regulated-industry procurement from generic e-commerce.
   • Integration back into institutional finance systems is what makes the record auditable; without the ERP hand-off the platform is another shadow ledger.

07Value chains and production pipelines#

Industrial pipeline for laboratory asset and consumable procurement (ISO 9001 purchasing controls)#

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Asset & stock baseline │ ───> │ 2. Booking & consumption  │
└───────────────────────────┘      └───────────────────────────┘
                                                 │
                                                 ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Multi-supplier sourcing│ <─── │ 3. Requisition raised     │
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Approval & PO issue    │ ───> │ 6. Receipt & reconciliation│
└───────────────────────────┘      └───────────────────────────┘

Stage 1: Asset & stock baseline

Every instrument, reagent lot and consumable is registered once against a location path and an owner. The input is the existing pile of spreadsheets and purchase records; the output is a single register against which every later step resolves, with expiry dates attached at lot level.

Stage 2: Booking & consumption

Shared instruments are reserved through a calendar that enforces training status, and consumption draws down the stock record as work proceeds. The output is both a conflict-free schedule and the utilisation history that later justifies or avoids a capital purchase.

Stage 3: Requisition raised

A low-stock or expiry alert, or a scientist’s direct request, opens a structured order request carrying a cost centre and grant code rather than an email. This is the point at which the purchase becomes traceable.

Stage 4: Multi-supplier sourcing

The platform ranks equivalent products across the supplier catalogue on price, lead time and availability — ZAGENO across 6,000+ suppliers — so the choice is a documented comparison rather than habit. Contracted pricing is applied automatically where an institution has negotiated it.

Stage 5: Approval & PO issue

The request routes through the lab head and finance against an approval matrix and budget position, then converts into a purchase order in the institution’s ERP. In regulated settings this is where the compliance trail is either created or lost; Labviva’s agentic architecture is aimed squarely at automating this step defensibly.

Stage 6: Receipt & reconciliation

Goods received are checked against the purchase order and posted back to inventory, closing the loop into stage 1 and producing the three-way match between order, delivery and invoice that an auditor asks for.